We have confirmed that unfortunately, our “Friends Making a Difference” Golf Tournament will not be held this year due to scheduling conflicts. Fingers crossed for 2022.
CORONAVIRUS ALERT: WNY BloodCare is continually monitoring information during this outbreak. Please visit our News section for the latest updates
One of the most common hereditary bleeding disorders, it is estimated that 20,000 people in the United States have Hemophilia in either a mild, moderate or severe form.
The two most common types of hemophilia are: hemophilia A, which is the result of a deficiency in the clotting factor VIII , and hemophilia B, which is caused by a deficiency of clotting factor IX. Other less common coagulation disorders treated are FV, FVII, FX, FXI, FXII, and FXIII.
Hemophilia is an X-linked genetic disorder, in which the hemophilia gene is carried by females on one of their X chromosomes. Women who are carriers of hemophilia have one normal X-chromosome, and one X-chromosome with an abnormal copy of the hemophilia gene. A woman who carries the abnormal hemophilia gene has a 50% risk of passing the gene on to a future son, who would then have hemophilia. There is also a 50% risk of passing the hemophilia gene on to a daughter, who would then be a carrier.
In about one-third of all cases, there is no family history of the disease, and hemophilia occurs as the result of a new or spontaneous mutation.